2018 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle View 
February 22, 2018Pernix Therapeutics to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 8
February 16, 2018Pernix Therapeutics Announces Launch of Authorized Generic Version of Treximet® by Company’s Subsidiary, Macoven Pharmaceuticals
February 6, 2018Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion
January 29, 2018Pernix Announces Patent Litigation Settlement Agreement with Actavis Concerning Zohydro® ER
January 5, 2018Pernix Announces Reorganization of Sales Force to Focus on Zohydro® ER with BeadTek™ and Silenor®